Ayten, M.* ; Straub, T.* ; Kaplan, L.* ; Hauck, S.M. ; Grosche, A.* ; Koch, S.F.*
CD44 signaling in Müller cells impacts photoreceptor function and survival in healthy and diseased retinas.
J. Neuroinflamm. 21:190 (2024)
Retinitis pigmentosa (RP), an inherited retinal disease, affects 1,5 million people worldwide. The initial mutation-driven photoreceptor degeneration leads to chronic inflammation, characterized by Müller cell activation and upregulation of CD44. CD44 is a cell surface transmembrane glycoprotein and the primary receptor for hyaluronic acid. It is involved in many pathological processes, but little is known about CD44's retinal functions. CD44 expression is also increased in Müller cells from our Pde6bSTOP/STOP RP mouse model. To gain a more detailed understanding of CD44's role in healthy and diseased retinas, we analyzed Cd44-/- and Cd44-/-Pde6bSTOP/STOP mice, respectively. The loss of CD44 led to enhanced photoreceptor degeneration, reduced retinal function, and increased inflammatory response. To understand the underlying mechanism, we performed proteomic analysis on isolated Müller cells from Cd44-/- and Cd44-/-Pde6bSTOP/STOP retinas and identified a significant downregulation of glutamate transporter 1 (SLC1A2). This downregulation was accompanied by higher glutamate levels, suggesting impaired glutamate homeostasis. These novel findings indicate that CD44 stimulates glutamate uptake via SLC1A2 in Müller cells, which in turn, supports photoreceptor survival and function.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cd44 ; Gliosis ; Glutamate ; Inflammation ; Müller Cells ; Retinitis Pigmentosa ; Slc1a2; Muller Glia; Extracellular-matrix; Transcriptional Regulation; Glutamate Transporters; Retinitis-pigmentosa; Preclinical Model; Up-regulation; Inflammation; Hyaluronan; Expression
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
1742-2094
e-ISSN
1742-2094
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 21,
Issue: 1,
Pages: ,
Article Number: 190
Supplement: ,
Series
Publisher
BioMed Central
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505700-001
A-630700-001
Grants
Ludwig-Maximilians-Universitt Mnchen (1024)
Copyright
Erfassungsdatum
2024-09-10